RR

Reena Rani

Active Director Director DIN 11135011
DIN 11135011 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2025
Shareholding value •••• Premium profile

About Reena Rani

Data last updated:

Reena Rani is a Director at Watran Pharmaceuticals Private Limited (since 2025) and Director at Aconwell Pharma Private Limited (since 2025). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹16.03 Cr; the largest is Watran Pharmaceuticals Private Limited at ₹8.42 Cr (FY 2025).

DIN 11135011
Primary Designation Director
Industry Pharma
First Appointment 23 Jun 2025
Oldest Company Age 7 yrs
Largest company Watran Pharmaceuticals Private Limited · ₹8.42 Cr (FY 2025)
Combined revenue ₹16.03 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Nov 20252019₹8.42 Cr (FY 2025)Active
Aconwell Pharma Private Limited U24290HR2019PTC081592
Director23 Jun 20252019₹7.61 Cr (FY 2024)Active

Board colleagues of Reena Rani

Directorship timeline

Open interactive timeline →
Aconwell Pharma Private Limited
Watran Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reena Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Rani

Reena Rani currently holds 2 directorships: Watran Pharmaceuticals Private Limited (Director, since 15 Nov 2025, revenue ₹8.42 Cr (FY 2025)); Aconwell Pharma Private Limited (Director, since 23 Jun 2025, revenue ₹7.61 Cr (FY 2024)).

Reena Rani was first appointed on 23 Jun 2025 as Director at Aconwell Pharma Private Limited.

The 2 current companies of Reena Rani that report revenue have a combined latest revenue of ₹16.03 Cr: Watran Pharmaceuticals Private Limited ₹8.42 Cr (FY 2025); Aconwell Pharma Private Limited ₹7.61 Cr (FY 2024).

The current boards of Reena Rani's companies include Manjeet Kaur (Watran Pharmaceuticals Private Limited), Sachin Kumar (Watran Pharmaceuticals Private Limited), Neha Rani (Aconwell Pharma Private Limited), Rocky (Aconwell Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available